Urethritis
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Chronic Inflammatory Condition of the Male Genital Tract
Rapid Diagnostic Assay for Gonorrhea and Chlamydia
Establishing Baseline Sysmex UF-5000 Flow Cytometer Results in Healthy Men
NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)
Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)
Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced
Study to Improve Partner Services for STD Prevention